Biotricity Historical Balance Sheet
BTCY Stock | USD 1.21 0.03 2.42% |
Trend analysis of Biotricity balance sheet accounts such as Short Long Term Debt Total of 23.6 M, Other Current Liabilities of 977.3 K or Total Current Liabilities of 13.5 M provides information on Biotricity's total assets, liabilities, and equity, which is the actual value of Biotricity to its prevalent stockholders. By breaking down trends over time using Biotricity balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Biotricity latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Biotricity is a good buy for the upcoming year.
Biotricity Inventory |
|
Biotricity |
About Biotricity Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Biotricity at a specified time, usually calculated after every quarter, six months, or one year. Biotricity Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Biotricity and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Biotricity currently owns. An asset can also be divided into two categories, current and non-current.
Biotricity Balance Sheet Chart
Biotricity Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Biotricity uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Biotricity's Total Liabilities is fairly stable compared to the past year. Short Term Debt is likely to rise to about 6.2 M in 2024, whereas Other Current Liabilities is likely to drop slightly above 977.3 K in 2024. Add Fundamental
Total Assets
Total assets refers to the total amount of Biotricity assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Biotricity books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Biotricity balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Biotricity are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Accounts Payable
An accounting item on the balance sheet that represents Biotricity obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Biotricity are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Capital Stock
The total amount of a company’s capital funded by shareholders through the issue and subscription of shares.Most accounts from Biotricity's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Biotricity current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotricity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.At this time, Biotricity's Total Liabilities is fairly stable compared to the past year. Short Term Debt is likely to rise to about 6.2 M in 2024, whereas Other Current Liabilities is likely to drop slightly above 977.3 K in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 15.4M | 19.5M | 22.5M | 23.6M | Total Assets | 16.7M | 6.5M | 7.5M | 7.9M |
Biotricity balance sheet Correlations
Click cells to compare fundamentals
Biotricity Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Biotricity balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 2.0M | 4.4M | 16.7M | 6.5M | 7.5M | 7.9M | |
Short Long Term Debt Total | 2.3M | 4.7M | 15.4M | 19.5M | 22.5M | 23.6M | |
Other Current Liab | 427.6K | 3.6M | 520.7K | 1.0M | 1.2M | 977.3K | |
Total Current Liabilities | 3.8M | 10.5M | 4.9M | 11.2M | 12.8M | 13.5M | |
Total Stockholder Equity | (3.0M) | (6.8M) | (2.1M) | (19.8M) | (17.9M) | (17.0M) | |
Net Debt | 1.4M | 2.5M | 3.3M | 19.0M | 21.8M | 22.9M | |
Retained Earnings | (46.4M) | (62.8M) | (93.0M) | (112.6M) | (101.3M) | (96.2M) | |
Accounts Payable | 1.1M | 1.0M | 1.2M | 3.4M | 4.0M | 4.1M | |
Cash | 949.8K | 2.2M | 12.1M | 570.5K | 656.0K | 623.2K | |
Cash And Short Term Investments | 949.8K | 2.2M | 12.1M | 570.5K | 656.0K | 623.2K | |
Net Receivables | 623.3K | 1.8M | 2.4M | 1.8M | 2.1M | 2.2M | |
Common Stock Total Equity | 31.9K | 35.4K | 36.4K | 39.0K | 44.9K | 27.8K | |
Common Stock Shares Outstanding | 6.0M | 6.3M | 7.6M | 8.7M | 10.0M | 7.3M | |
Liabilities And Stockholders Equity | 2.0M | 4.4M | 16.7M | 6.5M | 7.5M | 7.9M | |
Non Current Liabilities Total | 1.2M | 780.9K | 14.0M | 15.2M | 17.5M | 18.3M | |
Other Stockholder Equity | 44.2M | 56.6M | 91.6M | 92.8M | 106.7M | 112.1M | |
Total Liab | 5.0M | 11.3M | 18.8M | 26.4M | 30.3M | 31.8M | |
Total Current Assets | 1.7M | 4.3M | 15.3M | 4.7M | 5.4M | 3.2M | |
Accumulated Other Comprehensive Income | (857.3K) | (634.2K) | (768.7K) | (152.8K) | (137.5K) | (144.4K) | |
Short Term Debt | 2.3M | 4.3M | 1.8M | 5.1M | 5.9M | 6.2M | |
Common Stock | 36.4K | 39.0K | 51.3K | 52.5K | 60.4K | 33.8K | |
Net Tangible Assets | (1.8M) | (3.0M) | (6.8M) | (2.1M) | (1.9M) | (2.0M) | |
Non Current Assets Total | 345.6K | 116.5K | 1.4M | 1.8M | 2.1M | 2.2M | |
Short Term Investments | 137.1K | 326.7K | 302.3K | 588.6K | 676.9K | 710.7K | |
Inventory | 85.7K | 272.5K | 842.9K | 2.3M | 2.7M | 2.8M | |
Other Current Assets | 137.1K | 326.7K | 406.3K | 588.6K | 676.9K | 710.7K | |
Short Long Term Debt | 2.1M | 4.3M | 1.5M | 4.8M | 5.5M | 5.8M | |
Net Invested Capital | (932.1K) | (2.2M) | 11.9M | (2.0M) | (2.3M) | (2.2M) | |
Net Working Capital | (2.1M) | (6.2M) | 10.5M | (6.4M) | (5.8M) | (5.5M) | |
Capital Stock | 36.4K | 39.0K | 51.3K | 52.5K | 60.4K | 47.2K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.MSFT | Microsoft | |
GM | General Motors | |
CRM | Salesforce |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotricity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.Note that the Biotricity information on this page should be used as a complementary analysis to other Biotricity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for Biotricity Stock analysis
When running Biotricity's price analysis, check to measure Biotricity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotricity is operating at the current time. Most of Biotricity's value examination focuses on studying past and present price action to predict the probability of Biotricity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotricity's price. Additionally, you may evaluate how the addition of Biotricity to your portfolios can decrease your overall portfolio volatility.
Global Correlations Find global opportunities by holding instruments from different markets | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
Is Biotricity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biotricity. If investors know Biotricity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biotricity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.75) | Revenue Per Share 1.319 | Quarterly Revenue Growth 0.209 | Return On Assets (0.95) | Return On Equity (41.01) |
The market value of Biotricity is measured differently than its book value, which is the value of Biotricity that is recorded on the company's balance sheet. Investors also form their own opinion of Biotricity's value that differs from its market value or its book value, called intrinsic value, which is Biotricity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biotricity's market value can be influenced by many factors that don't directly affect Biotricity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biotricity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biotricity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotricity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.